Developing and integrating experimental and computational tools to elucidate pathogenic events occurring in rare diseases
The GM program is composed of investigators with biomedical, engineering, and computer science backgrounds who work in close collaboration with the geneticists and molecular biologists within the Institute.
This makes TIGEM one of the few interdisciplinary institutes that applies computational biology approaches to genetic diseases.
The GM program plays a significant role at TIGEM, researchers are regularly encouraged to use innovative technologies and robust experimental and computational tools in their own research projects. These approaches include Next Generation Sequencing for DNA and RNA sequencing in single cells, machine learning approaches to drug repositioning, and microfluidics technology for cell culture and quantitative biology.
Coordinator: Diego di Bernardo